Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KTP 20% for Acute Pain in Tendonitis or Bursitis
NCT00903994Phase 2Completed
- Sponsor
- APR Applied Pharma Research
- Start
- Jun 2007
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Ketofen in tendonitis, bursitis, sponsored by APR Applied Pharma Research. Started Jun 2007; status: completed.
02
Drugs
Ketofen
03
Conditions
tendonitisbursitis
Beyond the preview
Go deeper on NCT00903994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00903994.